ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,567.30
-0.98%
S&P ASX All Technology
2,930.40
-1.06%
Brent Oil
86.59
0.20%
US Dollar vs AUD
1.55999
0.22%
Bitcoin
63,680.32
0.27%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avalo Therapeutics Inc (AVTX)

  7. Avalo Therapeutics Inc (AVTX) News

AVTX Avalo Therapeutics Inc

11.75
-0.26 (-2.16%)
Last Updated: 02:15:30
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Avalo Therapeutics Inc AVTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.26 -2.16% 11.75 02:15:30
Open Price Low Price High Price Close Price Previous Close
11.68 11.68 13.0199 12.01
more quote information »

Recent News

Date Time Source Heading
02/4/202422:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
30/3/202407:01GLOBEAvalo Reports 2023 Financial Results and Provides Business..
28/3/202407:01GLOBEAvalo Acquires Anti-IL-1β mAb and Announces Private..
15/2/202413:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202408:01EDGAR2Form 8-K - Current report
29/12/202309:05EDGAR2Form 8-K - Current report
27/12/202323:00GLOBEAvalo Therapeutics Announces 1-for-240 Reverse Stock Split
22/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:01EDGAR2Form 8-K - Current report
07/12/202323:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202323:01EDGAR2Form 8-K - Current report
07/12/202323:00GLOBEAvalo Encourages Stockholders to Vote FOR the Reverse Stock..
16/11/202323:15EDGAR2Form 8-K - Current report
09/11/202323:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:04EDGAR2Form 8-K - Current report
09/11/202323:00GLOBEAvalo Reports Third Quarter 2023 Financial Results and..
31/10/202322:21EDGAR2Form 8-K - Current report
31/10/202322:00GLOBEAvalo Completes Divestiture of AVTX-800 Series
20/10/202307:15EDGAR2Form ARS - Annual Report to Security Holders
20/10/202307:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/10/202307:01EDGAR2Form DEF 14A - Other definitive proxy statements
18/10/202307:02EDGAR2Form 8-K - Current report
06/10/202307:02EDGAR2Form PRE 14A - Other preliminary proxy statements
26/9/202321:04EDGAR2Form 8-K - Current report
26/9/202321:00GLOBEAvalo Therapeutics Successfully Eliminates $35 Million Debt..
14/9/202306:03EDGAR2Form 8-K - Current report
13/9/202323:12EDGAR2Form 8-K - Current report
12/9/202321:10EDGAR2Form 8-K - Current report
12/9/202321:00GLOBEAvalo Enters into Agreement to Divest AVTX-800 Series
11/9/202321:22EDGAR2Form 8-K - Current report
06/9/202321:00GLOBEAvalo to Present at the H.C. Wainwright 25th Annual Global..
15/8/202306:23EDGAR2Form 8-K - Current report
09/8/202306:11EDGAR2Form 8-K - Current report
08/8/202307:27EDGAR2Form 8-K - Current report
08/8/202307:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202321:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202321:01EDGAR2Form 8-K - Current report
03/8/202321:00GLOBEAvalo Reports Second Quarter 2023 Financial Results and..
21/7/202322:25EDGAR2Form 8-K - Current report
07/7/202306:01GLOBEAvalo to Participate in SVB Securities Therapeutics Forum
29/6/202322:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/6/202308:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/6/202321:00GLOBEAvalo Announces Topline Data from Phase 2 PEAK Trial for..
01/6/202321:00GLOBEAvalo to Present at the Jefferies Healthcare Conference
22/5/202321:00GLOBEAvalo Announces Appointment of Michael Croft, Ph.D. and Jeff..
15/5/202321:00GLOBEAvalo to Present at ATS 2023 Respiratory Innovation Summit
10/5/202321:00GLOBEAvalo to Present at the 2023 RBC Capital Markets Global..
05/5/202306:01GLOBEAvalo Reports First Quarter 2023 Financial Results and..

Your Recent History

NASDAQ
AVTX
Avalo Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved